When science fiction becomes science fact: AI for rare disease diagnosis – how Volv Global's work moves us from the imaginable to operational reality.
Volv Global at ISPOR Global 2026, presenting new research in collaboration with Sanofi on identifying new Pompe Disease endpoints
In Inflammatory Bowel Disease (IBD), steroids are considered a routine treatment, but repeated steroid exposure is a red flag that a care pathway is failing.
Discover how patient advocacy accelerates rare disease diagnosis and innovation, bringing technology, real-world data, and collaboration together to improve care.
Guest article by Rareatives reflecting on Rare Disease Day and why awareness, patient stories, and advocacy play a vital role in supporting the rare disease community.
Explore why diagnostic delays in cancer remain a major challenge and how earlier diagnosis, better data, and healthcare collaboration can improve patient outcomes.
